Ionis Pharmaceuticals, Inc. Share-based Payment Arrangement, Amount Capitalized
Ionis Pharmaceuticals, Inc. (IONS) reported Share-based Payment Arrangement, Amount Capitalized of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Share-Based Payment Arrangement, Expensed and Capitalized, Amount
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2026-07-29
- Ionis Pharmaceuticals, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Ionis Pharmaceuticals, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2026-03-31 was $18.00K, a 96.33% decline year-over-year.
- Ionis Pharmaceuticals, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2025-12-31 was $355.00K, a 21.16% increase year-over-year.
- Ionis Pharmaceuticals, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2025-09-30 was $435.00K, a 14.03% decline year-over-year.
- Ionis Pharmaceuticals, Inc. share-based payment arrangement, amount capitalized for fiscal 2025 was $1.79M, a 124.03% increase from fiscal 2024.
- Ionis Pharmaceuticals, Inc. share-based payment arrangement, amount capitalized for fiscal 2024 was $799.00K.
- Ionis Pharmaceuticals, Inc. share-based payment arrangement, amount capitalized for fiscal 2023 was $0.00.
- Ionis Pharmaceuticals, Inc. share-based payment arrangement, amount capitalized for fiscal 2022 was $0.00.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 9 month | Share-based Payment Arrangement, Amount Capitalized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-29 | $18.00K 10-Q · filed 2026-07-29 | $373.00K derived: sum of 3 quarters · filed 2026-07-29 | $808.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $18.00K 10-Q · filed 2026-04-29 | $373.00K derived: sum of 2 quarters · filed 2026-04-29 | $808.00K derived: sum of 3 quarters · filed 2026-04-29 | $1.32M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $355.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $790.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.30M derived: sum of 3 quarters · filed 2026-07-29 | $1.79M 10-K · filed 2026-02-26 |
| 2025-09-30 | $435.00K 10-Q · filed 2025-10-29 | $944.00K derived: sum of 2 quarters · filed 2026-07-29 | $1.44M 10-Q · filed 2025-10-29 | $1.73M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $509.00K 10-Q · filed 2026-07-29 | $1.00M 10-Q · filed 2026-07-29 | $1.29M derived: sum of 3 quarters · filed 2026-07-29 | $1.80M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $491.00K 10-Q · filed 2026-04-29 | $784.00K derived: sum of 2 quarters · filed 2026-04-29 | $1.29M derived: sum of 3 quarters · filed 2026-04-29 | $1.29M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $293.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $799.00K derived: sum of 2 quarters · filed 2026-02-26 | $799.00K derived: sum of 3 quarters · filed 2026-02-26 | $799.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $506.00K 10-Q · filed 2025-10-29 | $506.00K derived: sum of 2 quarters · filed 2025-10-29 | $506.00K 10-Q · filed 2025-10-29 | $506.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 10-Q · filed 2025-07-30 | $0.00 10-Q · filed 2025-07-30 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $0.00 10-Q · filed 2025-04-30 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | ||
| 2022-12-31 | $0.00 10-K · filed 2025-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |